Gayle Hamilton, Director, RBQM, Digital Trial Management Suite, at IQVIA, is an experienced Risk-Based Monitoring project advisor and project lead with a strong background in clinical operations and project management. She has supported study trial teams and IT development in RBQM implementation across all phases and therapeutic areas, driving the development of processes, tools, and systems. Gayle is also experienced in assuring high quality business performance of clinical operations within global projects.
As Associate Director, RBQM, Digital Trial Management Suite, at IQVIA, Adrian brings expertise spanning R&D and clinical life sciences, business analysis, process design & improvement, and product implementation. He is currently a lead for IQVIA’s Risk-Based Quality Management SaaS solution. Adrian holds an MBA from the McDonough School of Business at Georgetown University in addition to an MSc in Pharmacology from The Johns Hopkins University School of Medicine and a BSc in Biochemistry from Temple University.
Risk-based quality management, or RBQM, is the process by which pharmaceutical organizations monitor and manage quality throughout clinical trials.